Eloxx Pharma (ELOX) Stock Price, Quote, News & History | Benzinga

Eloxx Pharmaceuticals Inc (ELOX) Stock Price, Quote, News & History

ELOXNASDAQ

Trade with Public

Trade with Public

$15.07

-0.93-5.81%

At close: Aug 28, 5:00 PM EST

$18.53

3.4622.96%

After Hours: Aug 27, 7:00 AM EST

OverviewNews Earnings Forecast Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$16.22

Close

$15.07

Volume / Avg.

32.10K / 58.82K

Day Range

$15.07 - $16.80

52 Wk Range

0.00 - 23.40

Market Cap

$63.67M

P/E Ratio

4.71

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

0.8%

Days to Cover

1

Recent Eloxx Pharmaceuticals Inc News

Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration of up to $200 million in cash.

Lisa Levin

Why US Steel Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket

Gainers AGBA Group Holding Limited (NASDAQ: AGBA) shares surged 49.4% to $1.31 in pre-market trading after the company reported a 325% year-over-year growth in its second-quarter revenue.

Lisa Levin

Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Lisa Levin

Why Senmiao Technology Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

Gainers Jiuzi Holdings, Inc. (NASDAQ: JZXN) shares surged 106.8% to $5.77 in pre-market trading. The stock began trading on a 1:18 reverse split on July 10.

Lisa Levin

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-16.02M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

77.41M

Free Cash Flow (TTM)

-16.02M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

61.39M

Analyst Trends and Forecast

2

Jul

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$48.00M

PE Ratio (TTM)

4.71

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.23

Earnings Yield % (TTM)

21.24%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$13.51

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

$600.00K

LT Debt Repayment (TTM)

$0

Total Cash

$61.96M

Debt to Equity

-

Issuance of Debt (TTM)

$600.00K

Repayment of Debt (TTM)

$0

Key Statistics

Open

$16.22

Close

$15.07

Volume / Avg.

32.10K / 58.82K

Day Range

$15.07 - $16.80

52 Wk Range

0.00 - 23.40

Market Cap

$63.67M

P/E Ratio

4.71

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

0.8%

Days to Cover

1

About

Sector

Health Care

Industry

Pharmaceuticals

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (N...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Eloxx Pharma (ELOX) stock?

A

You can purchase shares of Eloxx Pharma (NASDAQ:ELOX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Eloxx Pharma (ELOX) competitors?

A

Other companies in Eloxx Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Eloxx Pharma (ELOX) stock?

A

Eloxx Pharma has a consensus price target of $40.33.

Q

What is the current price for Eloxx Pharma (ELOX)?

A

The stock price for Eloxx Pharma (NASDAQ: ELOX) is $18.53 last updated August 27, 2026 at 7:00 AM EDT.

Q

Does Eloxx Pharma (ELOX) pay a dividend?

A

There are no upcoming dividends for Eloxx Pharma.

Q

When is Eloxx Pharma (NASDAQ:ELOX) reporting earnings?

A

Eloxx Pharma does not have any upcoming earnings scheduled.

Q

Is Eloxx Pharma (ELOX) going to split?

A

There is no upcoming split for Eloxx Pharma.

Q

What sector and industry does Eloxx Pharma (ELOX) operate in?

A

Eloxx Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.